参考文献/References:
[1] 刘芳,赵璐,吴琳,等.基于严重程度临床分级的川崎病冠状动脉病变的治疗和管理评价[J].中华儿科杂志,2015,53(9):690-695.
[2] 赵春娜,杜忠东,高灵灵.川崎病儿童冠状动脉病变危险因素分析[J].中华实用儿科临床杂志,2016,31(9):659-661.
[3] 吴守振,张晓燕,周南,等.川崎病患者CD4+ T细胞中血清和糖皮质激素诱导的激酶1(SGK1)表达上调且与RORC及IL-17A正相关[J].细胞与分子免疫学杂志,2015,31(10):1378-1382.
[4] 段炤,林智平,刘青,等.CD4+CD25+调节性T淋巴细胞与辅助性T淋巴细胞17在川崎病发病机制中的作用[J].中华实用儿科临床杂志,2017,32(9):652-655.
[5] SEHGAL S,CHEN X G,ANG J Y,et al.Epidemiology,clinical presentation,and outcomes of kawasaki disease among hospitalized children in an inner city hospital before and after publication of the American Academy of Pediatrics/American Heart Association Guidelines for treatment of Kawasaki disease:an 11-year period[J].Clin Pediatr,2012,54(13):1283-1289.
[6] PUHAKKA L,SAAT R,KLOCKARS T,et al.Retropharyngeal involvement in Kawasaki disease:a report of four patients with retropharyngeal edema verified by magnetic resonance imaging[J].Int J Pediatr Otorhinolaryngol,2014,78(10):1774-1778.
[7] 狄亚珍,吴菱,钟世玲,等.血N末端脑利钠肽原及高密度脂蛋白胆固醇对川崎病心血管损害预测价值的研究[J].中华风湿病学杂志,2014,18(3):170-175.
[8] 沈方方,章爱莲,朱雯,等.川崎病免疫功能和炎症因子检测及临床意义[J].中国妇幼健康研究,2015,26(4):1201-1203.
[9] 郭红梅,韩彦彦.川崎病病因及其发病机制研究进展[J].医学综述,2015,21(23):4260-4263.
[10] 黄可.手足口病并发脑炎患儿T淋巴细胞亚群的变化[J],新乡医学院学报,2015,32(8):766-767.
[11] 蒋勇,赵梦,李维禧,等.初始剂量静脉用丙种球蛋白治疗无反应川崎病的临床特征和预测指标[J].中华实用儿科临床杂志,2015,30(9):676-680.
[12] 闵锋,朱少元,李娇春,等.两种剂量丙种免疫球蛋白对川崎病患儿冠状动脉病变及血清基质金属蛋白酶含量影响的比较[J].东南大学学报(医学版),2015,34(6):942-945.
[13] 符敏,吴伟,陆晓和,等.实验性自身免疫性葡萄膜炎T淋巴细胞亚群与Treg细胞的表达研究[J].眼科新进展,2016,36(3):227-230.
[14] AOYAGI R,HAMADA H,SATO Y,et al.Study protocol for a phase III multicentre,randomised,open-label,blinded-end point trial to evaluate the efficacy and safety of immunoglobulin plus cyclosporin A in patients with severe Kawasaki disease (KAICA Trial)[J].BMJ Open,2015,5(12):e009562.
[15] 栗枫筠.小儿川崎病病因及发病机制研究现状[J].武警后勤学院学报(医学版),2016,25(9):773-777.
[16] WAKIGUCHI H,HASEGAWA S,SUZUKI Y,et al.Relationship between T-cell HLA-DR expression and intravenous immunoglobulin treatment response in Kawasaki disease[J].Pediatr Res,2015,77(4):536-540.
[17] 江彦秋,黄先玫.川崎病的免疫与遗传学发病机制研究进展[J].中华实用儿科临床杂志,2017,32(9):717-720.
相似文献/References:
[1]谭 军,张继轩,吴新艳,等.大剂量川芎嗪治疗高血压性脑出血急性期疗效观察[J].新乡医学院学报,2002,19(03):204.
[2]崔光琴,王凯。.脑梗死70例急性期血压变化[J].新乡医学院学报,2003,20(06):447.
[3]胡勇军,杨 红,王 丹,等.彩色多普勒超声心动图对川崎病冠状动脉瘤的诊断价值[J].新乡医学院学报,2003,20(04):265.
[4]胡勇军,杨 红,王 丹,等.彩色多普勒超声心动图对川崎病冠状动脉瘤的诊断价值[J].新乡医学院学报,2003,20(04):265.
[5]杜志刚,王艳玲,伊红丽,等.急性期脑梗死患者的心电图改变[J].新乡医学院学报,2009,26(03):296.
[6]侯维纳,吕爱婷,冯迎军.血清成纤维细胞生长因子23和Klotho水平与川崎病患儿冠状动脉损伤的关系[J].新乡医学院学报,2019,36(10):932.[doi:10.7683/xxyxyxb.2019.10.007]
HOU Wei-na,LYU Ai-ting,FENG Ying-jun.Relationship between the serum levels of fibroblast growth factor 23 and Klotho and coronary artery injury in children with Kawasaki disease[J].Journal of Xinxiang Medical University,2019,36(10):932.[doi:10.7683/xxyxyxb.2019.10.007]
[7]欧阳冰,唐林芬,戚胡敏,等.甲泼尼龙联合丙种球蛋白治疗川崎病疗效观察[J].新乡医学院学报,2018,35(10):907.[doi:10.7683/xxyxyxb.2018.10.014]
OUYANG Bing,TANG Lin-fen,QI Hu-min,et al.Effect of methylprednisolone combined with gamma globulin in the treatment of Kawasaki disease[J].Journal of Xinxiang Medical University,2018,35(10):907.[doi:10.7683/xxyxyxb.2018.10.014]